Detalhe da pesquisa
1.
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation.
Cancer Immunol Immunother
; 71(4): 865-874, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34462870
2.
A phase II, open-label, single-arm trial of carboplatin plus etoposide with bevacizumab and atezolizumab in patients with extended-stage small-cell lung cancer (CeLEBrATE study): background, design and rationale.
Future Oncol
; 18(7): 771-779, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-35068173
3.
A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?
Support Care Cancer
; 30(3): 2455-2465, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34779921
4.
PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort.
J Transl Med
; 19(1): 270, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34167578
5.
Second-line Eribulin in Triple Negative Metastatic Breast Cancer patients. Multicentre Retrospective Study: The TETRIS Trial.
Int J Med Sci
; 18(10): 2245-2250, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33859534
6.
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence.
J Cell Physiol
; 235(11): 7900-7910, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31943171
7.
The treatment paradigm of right-sided metastatic colon cancer: harboring BRAF mutation makes the difference.
Int J Colorectal Dis
; 35(8): 1513-1527, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-32382835
8.
Clinical and psychometric validation of the BreSAS questionnaire module for symptom assessment among breast cancer survivors.
Support Care Cancer
; 28(3): 1051-1058, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31177390
9.
The PERSONS score: A new tool for cancer patients' symptom assessment in simultaneous care and home care settings.
Palliat Support Care
; 18(1): 33-38, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31434598
10.
Clinical Outcomes of Patients with Advanced Cancer and Pre-Existing Autoimmune Diseases Treated with Anti-Programmed Death-1 Immunotherapy: A Real-World Transverse Study.
Oncologist
; 24(6): e327-e337, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30796151
11.
Early fatigue in cancer patients receiving PD-1/PD-L1 checkpoint inhibitors: an insight from clinical practice.
J Transl Med
; 17(1): 376, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31730009
12.
Prophylactic use of antiemetics for prevention of opioid-induced nausea and vomiting: a survey about Italian physicians' practice.
Support Care Cancer
; 27(9): 3531-3535, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-30684048
13.
What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudes.
J Oncol Pharm Pract
; 25(6): 1439-1444, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31042135
14.
The PERSONS score for symptoms assessment in simultaneous care setting: A pilot study.
Palliat Support Care
; 17(1): 82-86, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29792235
15.
"Vessels in the Storm": Searching for Prognostic and Predictive Angiogenic Factors in Colorectal Cancer.
Int J Mol Sci
; 19(1)2018 01 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29351242
16.
Topical Menthol for Treatment of Chemotherapy-induced Peripheral Neuropathy.
Indian J Palliat Care
; 23(3): 350-352, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-28827946
17.
Dose-dense nonpegylated liposomal Doxorubicin and docetaxel combination in breast cancer: dose-finding study.
Oncologist
; 20(2): 109-10, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25601964
18.
Worse prognosis of KRAS c.35 G > A mutant metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx).
BMC Med
; 11: 59, 2013 Mar 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-23497191
19.
The use of fentanyl buccal tablets for breakthrough pain by using doses proportional to opioid basal regimen in a home care setting.
Support Care Cancer
; 21(8): 2335-9, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-23564072
20.
Prognostic value of KRAS genotype in metastatic colorectal cancer (MCRC) patients treated with intensive triplet chemotherapy plus bevacizumab (FIr-B/FOx) according to extension of metastatic disease.
BMC Med
; 10: 135, 2012 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23136868